πŸ‡ΊπŸ‡Έ FDA
Patent

US 9827255

Fumagillol derivatives

granted A61KA61K31/155A61K31/192

Quick answer

US patent 9827255 (Fumagillol derivatives) held by Takeda Pharmaceutical Company Limited expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/155, A61K31/192, A61K31/216, A61K31/336